Martina Garau

Martina Garau


Martina’s current research includes methods and applications of structured decision-making approaches such as Multi-Criteria Decision Analysis (MCDA) in healthcare decision making; economic issues posed by the development and provision of treatments for rare diseases; value based assessments and HTA systems in high and middle income countries. She has over 15 years of experience leading projects for a variety of organisations, including global life sciences companies, non-profit research organisations, charities and trade associations. She has an MSc in Economics from the University of York and a first degree in economics from the University of Cagliari in Italy.

Recent publications:

Cubi-Molla, P., Errea, M., Zhang, K. and Garau, M., 2020. Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making? OHE Consulting report. Available at:

Chalkidou, K., Garau, M., Silverman, R., and Towse A. 2020. Blueprint for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Center for Global Development. Available at:

Garau, M., Hampson, G., Devlin, N. et al. (2018) Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL). PharmacoEconomics Open 2, 153–163 (2018).

Garau, M. and Devlin, N. (2017). Using MCDA as a decision aid in Health Technology Appraisal for coverage decisions: opportunities, challenges and unresolved questions. In “Multi-Criteria Decision Analysis to Support Healthcare Decisions” Marsh, K., Goetghebeur, M., Thokala, P., Baltussen, R. (Eds.). Springer book available at